• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1例采用S-1/多西他赛化疗成功治疗胃癌腹膜播散的病例]

[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].

作者信息

Okada Kazuyuki, Ebisui Chikara, Nushijima Yoichiro, Yanagisawa Tetsu, Okamura Shu, Fukuchi Nariaki, Murata Kohei, Yokouchi Hideoki, Kinuta Masakatsu

机构信息

Dept. of Surgery, Suita Municipal Hospital.

出版信息

Gan To Kagaku Ryoho. 2014 Nov;41(12):2361-3.

PMID:25731523
Abstract

A 66-year-old man underwent a curative operation for advanced gastric cancer (T4aN0M0, Stage IIB). A gastric cancer recurrence with paraaortic lymph node (PALN) metastasis was diagnosed fifteen months after the operation. Systemic chemotherapy was initiated, using a regimen of S-1/CDDP. After 7 courses, abdominal computed tomography (CT) examination indicated the regression of PALN swelling. However, peritoneal dissemination was detected in the neighborhood of the right kidney. S-1/docetaxel (S-1/DOC) was selected as the second-line chemotherapy. After 3 courses, the peritoneal dissemination could not be detected. Five years since the curative operation, the patient has been doing well, with no signs of recurrence. In summary, we successfully treated a case of peritoneal dissemination from gastric cancer with S-1/DOC chemo- therapy.

摘要

一名66岁男性接受了晚期胃癌(T4aN0M0,IIB期)的根治性手术。术后15个月诊断为胃癌复发并伴有主动脉旁淋巴结(PALN)转移。开始使用S-1/顺铂方案进行全身化疗。7个疗程后,腹部计算机断层扫描(CT)检查显示PALN肿大消退。然而,在右肾附近发现了腹膜播散。选择S-1/多西他赛(S-1/DOC)作为二线化疗方案。3个疗程后,未检测到腹膜播散。根治性手术后5年,患者情况良好,无复发迹象。总之,我们用S-1/DOC化疗成功治疗了一例胃癌腹膜播散病例。

相似文献

1
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].[1例采用S-1/多西他赛化疗成功治疗胃癌腹膜播散的病例]
Gan To Kagaku Ryoho. 2014 Nov;41(12):2361-3.
2
[A Case of Advanced Gastric Cancer with Peritoneal Dissemination Effectively Treated with S-1 and Docetaxel Combination Chemotherapy].[S-1与多西他赛联合化疗有效治疗晚期胃癌合并腹膜播散1例]
Gan To Kagaku Ryoho. 2015 Nov;42(12):2052-4.
3
[A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel].[1例胃癌根治术后腹膜播散复发的晚期胃癌患者经S-1与多西他赛联合化疗有效治疗]
Gan To Kagaku Ryoho. 2013 Nov;40(12):2244-6.
4
[A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
Gan To Kagaku Ryoho. 2013 Nov;40(12):2194-6.
5
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].两例伴有腹膜播散及魏尔啸转移的晚期胃癌经S-1与多西他赛联合治疗成功治愈
Gan To Kagaku Ryoho. 2010 Jan;37(1):147-50.
6
[Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination].
Gan To Kagaku Ryoho. 2015 Nov;42(12):2055-7.
7
[Advanced Gastric Cancer with Peritoneal Dissemination Treated with Conversion Surgery after S-1 and CDDP Chemotherapy - A Case Report].[S-1与顺铂化疗后行转化手术治疗的晚期胃癌伴腹膜播散——病例报告]
Gan To Kagaku Ryoho. 2018 Mar;45(3):471-473.
8
[A case of highly advanced gastric cancer with peritoneal dissemination -- a histological CR to S-1 and CDDP combination chemotherapy].[一例伴有腹膜播散的晚期胃癌——S-1与顺铂联合化疗后组织学完全缓解]
Gan To Kagaku Ryoho. 2015 Mar;42(3):355-8.
9
[A case of advanced gastric cancer with peritoneal dissemination successfully treated with S-1 and intraperitoneal docetaxel administration].
Gan To Kagaku Ryoho. 2012 Jan;39(1):119-22.
10
[Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1].[1例晚期胃癌伴腹膜播散患者经多西他赛、顺铂和S-1联合化疗后疗效良好并接受根治性切除术]
Gan To Kagaku Ryoho. 2013 Sep;40(9):1221-4.